1999
DOI: 10.1016/s0041-1345(99)00413-3
|View full text |Cite
|
Sign up to set email alerts
|

Orthotopic liver transplantation in patients over 60 years of age

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2001
2001
2017
2017

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 10 publications
0
4
0
Order By: Relevance
“…4,6,20 In this report, we investigated our single-center results using older donors and compared these based on both recipient and donor age, comparing age 60 years or older with age younger than 60, using 60 years because it has historically been used as an age cut-off. 6,14,18,21 In 857 liver transplant cases stratified based on these age specifications, we were unable to demonstrate any adverse impact based on donor age 60 or above. This included no increased risk of primary graft nonfunction (PNF), no increased rate of hepatic artery thrombosis (HAT), and no increased incidence of long-term graft dysfunction (including recurrent infection with HCV).…”
Section: Discussionmentioning
confidence: 68%
See 1 more Smart Citation
“…4,6,20 In this report, we investigated our single-center results using older donors and compared these based on both recipient and donor age, comparing age 60 years or older with age younger than 60, using 60 years because it has historically been used as an age cut-off. 6,14,18,21 In 857 liver transplant cases stratified based on these age specifications, we were unable to demonstrate any adverse impact based on donor age 60 or above. This included no increased risk of primary graft nonfunction (PNF), no increased rate of hepatic artery thrombosis (HAT), and no increased incidence of long-term graft dysfunction (including recurrent infection with HCV).…”
Section: Discussionmentioning
confidence: 68%
“…The incidence of severe viral C recurrence, diagnosed by liver biopsy, was also similar across donor age groups. 21 The recent introduction of highly effective hepatitis C antiviral agents will likely reduce this concern because many transplant recipients will have been treated before liver transplantation, or will be able to undergo antiviral treatment in the post-transplantation setting. We previously reported our initial experience with use of older donors for liver transplantation, 18 and that initial report demonstrated equivalent results in short-and mediumterm follow-up.…”
Section: Discussionmentioning
confidence: 99%
“…The discrepancy between available donor organs and patients awaiting transplantation has led to evaluation of selection and listing criteria for LT, including transplantation of elderly patients (older than 65 yr), with the goal of maximizing survival outcomes (15–19). Numerous studies have confirmed that transplant surgery can be performed safely in elderly patients (12, 20–29) (Table 4). Kemmer (29) in a recent review describe the transplantation trends in the older recipient using the United Network for Organ Sharing (UNOS) database.…”
Section: Discussionmentioning
confidence: 96%
“…We classified the recipients into 2 groups: an elderly group (E group; ≥60 years of age) and a younger group (Y group; <60 years of age), with age 60 years established as the cutoff due to its usage in similar studies. 8-10 Recipient variables, including the characteristics, patient survival, and cause of death, were collected and used for the analysis. To assess the impact of recipient factors on the survival, a Cox proportional analysis was performed in all recipients as well as in the Y and E groups.…”
Section: Methodsmentioning
confidence: 99%